NCT06661239

Brief Summary

The benson Relaxation Technique (BRT), developed by Dr. Herbert Benson, is a method aimed at reducing stress and anxiety through a series of simple steps designed to elicit the "Relaxation Response." This response is a physiological state that counteracts the harmful effects of stress, characterized by decreased heart rate, lower metabolism, and reduced breathing rate

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 19, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 28, 2024

Completed
4 days until next milestone

Study Start

First participant enrolled

November 1, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

August 6, 2025

Status Verified

June 1, 2024

Enrollment Period

9 months

First QC Date

October 19, 2024

Last Update Submit

August 1, 2025

Conditions

Keywords

benson relaxationOncology/ cancer patientsClinical outcomes

Outcome Measures

Primary Outcomes (6)

  • Heart rate

    measure heart rate per min

    daily for three days

  • Blood pressure

    measure blood pressure in mmHg

    daily for three days

  • Respiratory rate

    measure respiratory rate per min

    daily for three days

  • The Rhodes Index of Nausea, Vomiting, and Retching

    It is a self-report tool designed to assess the severity and impact of nausea, vomiting, and retching on patients' 5-point categorical scales, the interval of each category was (maximum possible score/4-1 ) with the score being zero in the "none" category. For example, if the maximum possible score was 32, then, none: 0, mild: 1-8, moderate: 9-16, severe: 17-24, great: 24-32.

    daily for three days

  • The Numeric Pain Rating Scale

    The patient is asked to make three pain ratings, corresponding to current, best and worst pain experienced over the past 24 hours. scale is the most widely used single-dimension assessment scale.The total score is divided into 4 main categories: zero, which indicates no pain; 1-3 grades, which indicates mild pain; 4-6 grades, which indicate moderate pain; and 7-10 grades, which indicate severe pain

    daily for three days

  • Insomnia Severity Index Scale

    The Insomnia Severity Index (ISI) is a widely used self-report questionnaire designed to assess the severity of insomnia. It consists of seven questions, each rated on a scale that reflects the severity of sleep problems experienced over the last two weeks. The total score is calculated by summing the responses to all seven items, with potential scores ranging from 0 to 28. Total Score Calculation 0-7: No clinically significant insomnia 8-14: Subthreshold insomnia 15-21: Clinical insomnia (moderate severity) 22-28: Clinical insomnia (severe)

    daily for three days

Secondary Outcomes (1)

  • Icu length

    an average three months

Study Arms (2)

The benson group

EXPERIMENTAL

Patients who received the intervention

Behavioral: benson relaxation

Control group

PLACEBO COMPARATOR

Patients who receive routine care in units

Behavioral: Routine care in unit

Interventions

The benson relaxation consisted of the following steps: (1) Sitting or lying down quietly in a comfortable position; (2) Closing eyes; (3) Deeply relaxing all muscles, beginning at the feet and progressing up to the face. Keeping them relaxed; (4) Breathing through the nose. (5) Maintaining a passive attitude and permitting relaxation to occur at its own pace; (6) Continuing for 15 minutes. When finished, sit quietly for several minutes, at first with eyes closed and later with eyes opened. Do not stand up for a few minutes. According to the agreement, the patients in both groups were required to perform the Benson relaxation technique regularly twice daily (morning and evening) for seven days in a row. Each session lasted 15 minutes

The benson group

The routine care include in the unit will be delivered to control group

Control group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Adult patients aged 18-60 years
  • diagnosed with cancer
  • alert and able to communicate.

You may not qualify if:

  • Patients who refused to participate in the study
  • Patients with cognitive impairment
  • Patient who unable to communicate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Nursing

Damanhūr, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The studied patients will be masked for the intervention
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: The Benson relaxation consisted of the following steps: (1) Sitting or lying down quietly in a comfortable position; (2) Closing eyes; (3) Deeply relaxing all muscles, beginning at the feet and progressing up to the face. Keeping them relaxed; (4) Breathing through the nose. (5) Maintaining a passive attitude and permitting relaxation to occur at its own pace; (6) Continuing for 15 minutes. When finished, sit quietly for several minutes, at first with eyes closed and later with eyes opened. Do not stand up for a few minutes. According to the agreement, the patients in both groups were required to perform the Benson relaxation technique regularly twice daily (morning and evening) for seven days in a row. Each session lasted 15 minutes.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 19, 2024

First Posted

October 28, 2024

Study Start

November 1, 2024

Primary Completion

August 1, 2025

Study Completion

August 1, 2025

Last Updated

August 6, 2025

Record last verified: 2024-06

Locations